Immunology drug developer Odyssey prices upsized IPO
Odyssey Therapeutics, Inc. Common Stock · Now $16.96
+9.3% in 3d after detection
Post-detection moves
1h
—
1d
+6.3%
3d
+9.3%
7d
+3.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS